Co-Diagnostics (OTC:CODX) reported quarterly losses of $(16.65) per share. This is a 53.88 percent decrease over losses of $(10.82) per share from the same period last year. The company reported $263.922 thousand in sales this quarter. This is a 76.74 percent increase over sales of $149.325 thousand the same period last year.